BioGend Therapeutics Co., Ltd. (TPEX:6733)
28.30
-0.70 (-2.41%)
May 8, 2026, 1:30 PM CST
-0.70% (1Y)
| Market Cap | 3.52B +10.9% |
| Revenue (ttm) | 229.81M +28.0% |
| Net Income | -67.11M |
| EPS | -0.54 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 149,955 |
| Average Volume | 238,047 |
| Open | 29.00 |
| Previous Close | 29.00 |
| Day's Range | 28.25 - 29.30 |
| 52-Week Range | 27.00 - 49.15 |
| Beta | 0.15 |
| RSI | 29.11 |
| Earnings Date | Aug 7, 2026 |